Explore

Trendline Trendline
Merck Ends Development of TROP ADC Amidst Strategic Pipeline Adjustments

Merck Ends Development of TROP ADC Amidst Strategic Pipeline Adjustments

Merck Ends Development of TROP ADC Amidst Strategic Pipeline Adjustments
Trendline Trendline
Merck Discontinues Early-Stage TROP ADC Amid Strategic Shifts in Oncology

Merck Discontinues Early-Stage TROP ADC Amid Strategic Shifts in Oncology

Merck Discontinues Early-Stage TROP ADC Amid Strategic Shifts in Oncology
Reuters Reuters
Big Pharma M&A set for mega year as patent expiries drive deal urgency

Big Pharma M&A set for mega year as patent expiries drive deal urgency

By Christy Santhosh and Sriparna Roy May 1 (Reuters) - Biotech dealmaking is on pace for a bumper year in 2026, with large drugmakers on an acquisition spree to boost their pipelines ahead of upcoming patent losses.
Trendline Trendline
Merck Reports Strong Q1 Results Driven by Keytruda Sales, Adjusts 2026 Outlook

Merck Reports Strong Q1 Results Driven by Keytruda Sales, Adjusts 2026 Outlook

Merck Reports Strong Q1 Results Driven by Keytruda Sales, Adjusts 2026 Outlook
Trendline Trendline
Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies

Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies

Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies
Trendline Trendline
Eli Lilly CEO David Ricks Discusses Quarterly Earnings and New Product Launch

Eli Lilly CEO David Ricks Discusses Quarterly Earnings and New Product Launch

Eli Lilly CEO David Ricks Discusses Quarterly Earnings and New Product Launch
Trendline Trendline
Bambusa Therapeutics Completes Enrollment for Atopic Dermatitis Drug Trial

Bambusa Therapeutics Completes Enrollment for Atopic Dermatitis Drug Trial

Bambusa Therapeutics Completes Enrollment for Atopic Dermatitis Drug Trial
Trendline Trendline
BioOrbit Secures £9.8M to Advance Space-Based Cancer Drug Manufacturing

BioOrbit Secures £9.8M to Advance Space-Based Cancer Drug Manufacturing

BioOrbit Secures £9.8M to Advance Space-Based Cancer Drug Manufacturing
Trendline Trendline
Bicycle Therapeutics Advances Cancer Drug Development with Promising Clinical Data

Bicycle Therapeutics Advances Cancer Drug Development with Promising Clinical Data

Bicycle Therapeutics Advances Cancer Drug Development with Promising Clinical Data
Trendline Trendline
Molecular Partners' MP0317 Shows Promise in Tumor-Localized CD40 Activation, Phase 2 Trial Initiated

Molecular Partners' MP0317 Shows Promise in Tumor-Localized CD40 Activation, Phase 2 Trial Initiated

Molecular Partners' MP0317 Shows Promise in Tumor-Localized CD40 Activation, Phase 2 Trial Initiated
Trendline Trendline
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins to Advance Cancer Vaccine Platform

Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins to Advance Cancer Vaccine Platform

Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins to Advance Cancer Vaccine Platform
Trendline Trendline
Bambusa Therapeutics Completes Enrollment for Phase 1b/2a Trial of BBT001 for Atopic Dermatitis

Bambusa Therapeutics Completes Enrollment for Phase 1b/2a Trial of BBT001 for Atopic Dermatitis

Bambusa Therapeutics Completes Enrollment for Phase 1b/2a Trial of BBT001 for Atopic Dermatitis